"These long-term benefits are harder to achieve with GLP-1 medicines alone, as many patients stop using the medications over time." According to the authors, the study has some limitations
Combined with your clinical history, kidney function, cardiovascular status, and treatment response so far, genetic context contributes to individualized therapy decisionsnot replaces them
7 Pre-treatment with mGIPR-Ab and mGIPR-Ab/P3 blocks DA-GIP- induced c-FOS in the mouse brain
Comparing Retatrutide and Tirzepatide Given their shared origin at Eli Lilly, Retatrutide and Tirzepatide are both fascinating studies in modern weight loss medications as incretin-based therapies
In some ways, were trying to solve the evidence-translation gap. Once a drug or therapy has been demonstrated safe and effective in clinical trials, its no secret that it takes a long time to be adopted into mainstream practice, he said